Enhanced anti-tumor efficacy and mechanisms associated with docetaxel-piperine combination- in vitro and in vivo investigation using a taxane-resistant prostate cancer model.
about
Enhanced anti-tumor efficacy and mechanisms associated with docetaxel-piperine combination- in vitro and in vivo investigation using a taxane-resistant prostate cancer model.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Enhanced anti-tumor efficacy a ...... sistant prostate cancer model.
@en
Enhanced anti-tumor efficacy a ...... sistant prostate cancer model.
@nl
type
label
Enhanced anti-tumor efficacy a ...... sistant prostate cancer model.
@en
Enhanced anti-tumor efficacy a ...... sistant prostate cancer model.
@nl
prefLabel
Enhanced anti-tumor efficacy a ...... sistant prostate cancer model.
@en
Enhanced anti-tumor efficacy a ...... sistant prostate cancer model.
@nl
P2093
P2860
P356
P1433
P1476
Enhanced anti-tumor efficacy a ...... sistant prostate cancer model.
@en
P2093
Chenrui Li
Christopher Wai Kei Lam
Moses S S Chow
Rebecca Lucinda Ka Yan Ho
Ying Huang
Zhijun Wang
P2860
P304
P356
10.18632/ONCOTARGET.23235
P407
P577
2017-12-14T00:00:00Z